Literature DB >> 12816521

An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity: a plausible underlying mechanism?

B Marples1, B G Wouters, M C Joiner.   

Abstract

The survival of asynchronous and highly enriched G1-, S- and G2-phase populations of Chinese hamster V79 cells was measured after irradiation with 60Co gamma rays (0.1-10 Gy) using a precise flow cytometry-based clonogenic survival assay. The high-dose survival responses demonstrated a conventional relationship, with G2-phase cells being the most radiosensitive and S-phase cells the most radioresistant. Below 1 Gy, distinct low-dose hyper-radiosensitivity (HRS) responses were observed for the asynchronous and G2-phase enriched cell populations, with no evidence of HRS in the G1- and S-phase populations. Modeling supports the conclusion that HRS in asynchronous V79 populations is explained entirely by the HRS response of G2-phase cells. An association was discovered between the occurrence of HRS and the induction of a novel G2-phase arrest checkpoint that is specific for cells that are in the G2 phase of the cell cycle at the time of irradiation. Human T98G cells and hamster V79 cells, which both exhibit HRS in asynchronous cultures, failed to arrest the entry into mitosis of damaged G2-phase cells at doses less than 30 cGy, as determined by the flow cytometric assessment of the phosphorylation of histone H3, an established indicator of mitosis. In contrast, human U373 cells that do not show HRS induced this G2-phase checkpoint in a dose-independent manner. These data suggest that HRS may be a consequence of radiation-damaged G2-phase cells prematurely entering mitosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816521     DOI: 10.1667/rr3013

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  25 in total

Review 1.  Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Authors:  Anish Prasanna; Mansoor M Ahmed; Mohammed Mohiuddin; C Norman Coleman
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Non-problematic risks from low-dose radiation-induced DNA damage clusters.

Authors:  Daniel P Hayes
Journal:  Dose Response       Date:  2008-01-16       Impact factor: 2.658

3.  A Logarithmic Formula to Describe the Relationship between the Increased Radiosensitivity at Low Doses and the Survival at 2 Gray.

Authors:  Faika A Azooz; Suzan K Hashim
Journal:  Sultan Qaboos Univ Med J       Date:  2013-11-08

4.  Investigation of non-linear adaptive responses and split dose recovery induced by ionizing radiation in three human epithelial derived cell lines.

Authors:  Lorna A Ryan; Colin B Seymour; Carmel E Mothersill
Journal:  Dose Response       Date:  2009-08-06       Impact factor: 2.658

Review 5.  Assessing cancer risks of low-dose radiation.

Authors:  Leon Mullenders; Mike Atkinson; Herwig Paretzke; Laure Sabatier; Simon Bouffler
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

6.  The role of DNA damage repair and Chk2 protein in hyper-radiosensitivity of lung adenocarcinoma A549 cells.

Authors:  Hongge Wu; Qitian Chen; Yong Zhang; Gang Wu; Rui Meng; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

7.  Effects of G2-checkpoint dynamics on low-dose hyper-radiosensitivity.

Authors:  Oluwole Olobatuyi; Gerda de Vries; Thomas Hillen
Journal:  J Math Biol       Date:  2018-04-20       Impact factor: 2.259

Review 8.  Radiation exposure from imaging tests: is there an increased cancer risk?

Authors:  Patricia K Nguyen; Joseph C Wu
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-02

9.  VorinostatSAHA Promotes Hyper-Radiosensitivity in Wild Type p53 Human Glioblastoma Cells.

Authors:  Eric Diss; NarasimhaRao Nalabothula; Duc Nguyen; Elizabeth Chang; Young Kwok; France Carrier
Journal:  J Clin Oncol Res       Date:  2014-01-15

10.  Rad9A is required for G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibition.

Authors:  Deborah A Greer Card; Megan L Sierant; Scott Davey
Journal:  J Biol Chem       Date:  2010-03-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.